Neurofilaments as a Severity and Prognostic Marker in Guillain Barre Syndrome
Keywords -"neutrophil to lymphocyte ratio in encephalitis" and "neutrophil to lymphocyte ratio in autoimmune encephalitis"were searched in PubMed and EBSCO on April 24, 2024.Inclusion criteria was: (1) English peer-reviewed articles and (2) evaluation of NLR in autoimmune encephalitis in humans.Two independent searches were performed (N.K. and G.G.). ResultsInitial keyword search yielded 122 results, with 106 studies excluded.A total of 16 studies were included (two pediatric and 14 adult).Five studies were exclusively in NMDARE (one pediatric, four adult).Eight investigated definite (antibody-positive) AE and three included probable (antibody-negative) AE (one pediatric, two adult).Mean NLR cutoff was 4.48.In children, the NLR was associated with intubation and rehabilitation length of stay in NMDARE and disease severity in definite and probable AE.Of the eight definite AE adult studies, high NLR was associated with disease severity (2), ICU admission (1), poor neurological outcomes (3) and first-line treatment failure (2).In the two probable AE adult studies, high NLR was associated with first-line treatment failure (1) and poor neurological outcomes (1).In the four adult NMDARE studies, high NLR was associated with first-line treatment failure (1), disease severity (2), and poor neurological outcomes in patients requiring mechanical ventilation (1).Limitations include publication bias. ConclusionsNLR may be a prognostic marker for AE in children and adults.Study Supported By: N/A.
Authors
- Varun Rehani
- Anubhuti Dixit (ORCID: https://orcid.org/0000-0002-9414-2610)
- Bipan Sharma
- Deepinder Kaur Maini (ORCID: https://orcid.org/0000-0002-3351-365X)
- Satyan Nanda
- Rajiv Anand
- Sidarrth Prasad (ORCID: https://orcid.org/0009-0009-4028-489X)
Publication Details
- Journal
- Neurology
- Published
- 2024-10-08
- DOI
- https://doi.org/10.1212/01.wnl.0001051176.81847.b3
- Primary Topic
- Hereditary Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- Centers for Disease Control and Prevention